Vimarsana
Biggest News Aggregation in the World

Page 17 - Priya Singhal News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priya Singhal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priya Singhal Today - Breaking & Trending Today

Biogen's (BIIB) Overweight Rating Reaffirmed at Cantor Fitzgerald - Vimarsana News

Biogen's (BIIB) Overweight Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. The firm currently has a $311.00 target price on the biotechnology company’s stock. Several other research analysts have also recently issued reports on BIIB. Stifel Nicolaus dropped their price target […]

Biogen's QALSODY (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP Seite 1 - Vimarsana News

Biogen's QALSODY (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP Seite 1

23.02.2024 - SOD1-ALS is a devastating, uniformly fatal, and ultra-rare genetic form of ALS affecting less than 1,000 people in Europe1With QALSODY, Biogen has advanced the role of neurofilament in the development of new medicines for ALS, with the potential to ... Seite 1

Biogen (NASDAQ:BIIB) PT Lowered to $277.00 at Mizuho - Vimarsana News

Biogen (NASDAQ:BIIB) PT Lowered to $277.00 at Mizuho

Biogen (NASDAQ:BIIB – Get Free Report) had its price target cut by Mizuho from $355.00 to $277.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Mizuho’s price objective indicates a potential upside of 25.31% from the stock’s previous close. Other […]

Source: wkrb13.com
Fmr LLC Sells 1,279,470 Shares of Biogen Inc. (NASDAQ:BIIB) - Vimarsana News

Fmr LLC Sells 1,279,470 Shares of Biogen Inc. (NASDAQ:BIIB)

Fmr LLC lowered its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 48.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,361,051 shares of the biotechnology company’s stock after selling 1,279,470 shares during the quarter. Fmr LLC […]

Biogen Inc. (NASDAQ:BIIB) Shares Sold by HighTower Advisors LLC - Vimarsana News

Biogen Inc. (NASDAQ:BIIB) Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC cut its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 27.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,762 shares of the biotechnology company’s stock after selling 4,792 shares during the quarter. HighTower Advisors LLC’s holdings […]